Alternative Data for Angiodynamic
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | 17 | Sign up | Sign up | Sign up |
| Sentiment | 100 | Sign up | Sign up | Sign up |
| Webpage traffic | 11,000 | Sign up | Sign up | Sign up |
| Employee Rating | 64 | Sign up | Sign up | Sign up |
| Google Trends | N/A | Sign up | Sign up | Sign up |
| Patents | N/A | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Facebook Engagement | 6 | Sign up | Sign up | Sign up |
| Facebook Followers | 1,136 | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | 2 | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 1,067 | Sign up | Sign up | Sign up |
| X Followers | 1,584 | Sign up | Sign up | Sign up |
| X Mentions | 5 | Sign up | Sign up | Sign up |
| Youtube Subscribers | 1,850 | Sign up | Sign up | Sign up |
| News Mentions | N/A | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| Business Outlook | 44 | Sign up | Sign up | Sign up |
| Linkedin Employees | 979 | Sign up | Sign up | Sign up |
About Angiodynamic
AngioDynamics, Inc. designs, manufactures, and sells various medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and vascular access; and for use in oncology and surgical settings in the United States and internationally.
| Price | $10.24 |
| Target Price | Sign up |
| Volume | 404,980 |
| Market Cap | $428M |
| Year Range | $8.4 - $13.64 |
| Dividend Yield | 0% |
| Analyst Rating | 100% buy |
| Industry | Medical & Dental Instruments |
In the news
 |
AngioDynamics, Inc. (ANGO) Presents at 44th Annual J.P. Morgan Healthcare Conference TranscriptJanuary 14 - SeekingAlpha |
|
AngioDynamics, Inc. (ANGO) Presents at 44th Annual J.P. Morgan Healthcare Conference - SlideshowJanuary 14 - SeekingAlpha |
|
AngioDynamics, Inc. (ANGO) Q2 2026 Earnings Call TranscriptJanuary 5 - SeekingAlpha |
AngioDynamics, Inc. 2026 Q2 - Results - Earnings Call PresentationJanuary 5 - SeekingAlpha |
|
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q3 '25 | 76M | 34M | 42M | -11M | -4.8M | -0.100 |
| Q2 '25 | 80M | 38M | 42M | -6.1M | 2.2M | -0.030 |
| Q1 '25 | 72M | 33M | 39M | -4.4M | -330,000 | 0.030 |
| Q4 '24 | 73M | 33M | 40M | -11M | 1.8M | -0.040 |
| Q3 '24 | 67M | 31M | 37M | -13M | -1.9M | -0.110 |
Insider Transactions View All
| Weiss Lawrence T filed to buy 93,597 shares at $11.8. October 22 '25 |
| Trowbridge Stephen A filed to buy 256,629 shares at $11.2. October 14 '25 |
| Clemmer James C filed to buy 882,529 shares at $11.2. October 9 '25 |
| Nighan Warren JR filed to sell 41,817 shares at $12.3. January 17 '25 |
| Nighan Warren JR filed to buy 45,877 shares at $6.1. October 10 '24 |
Similar companies
Congress Trading View All
| Politician | Filing Date | Type | Size |
|---|---|---|---|
| Debbie Wasserman Schultz |
Oct 27, 25 | Sell | $1K - $15K |
| Debbie Wasserman Schultz |
Jul 28, 25 | Sell | $1K - $15K |
| Debbie Wasserman Schultz |
Jul 28, 25 | Buy | $1K - $15K |
Read more about Angiodynamic (ANGO) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, patents, 4chan mentions, facebook engagement, facebook followers, reddit mentions, stocktwits mentions, stocktwits subscribers, x followers, x mentions, youtube subscribers, news mentions, customer reviews, business outlook & linkedin employees.
FAQ - Angiodynamic
The Market Cap of Angiodynamic is $428M.
Currently, the price of one share of Angiodynamic stock is $10.24.
The ANGO stock price chart above provides a comprehensive visual representation of Angiodynamic's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Angiodynamic shares. Our platform offers an up-to-date ANGO stock price chart, along with technical data analysis and alternative data insights.
As of our latest update, Angiodynamic (ANGO) does not offer dividends to its shareholders. Investors interested in Angiodynamic should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
Some of the similar stocks of Angiodynamic are Align Technology, Dentsply, LeMaitre Vascular, iRhythm Technologies, and NovoCure.
